feed,title,long_url,short_url
SSRN,Interim Results from a Phase I Trial of Novel SARS-CoV-2 Beta Variant Receptor-Binding Domain Recombinant Protein and mRNA Vaccines as a 4 th Dose Booster,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4485603,
